Effect of Postural Change on Hemoglobin Level in Patients on the Intensive Care Unit
Postural change from supine to sitting
+ Mobilization to a chair
Anemia
+ Hematologic Diseases
+ Hemic and Lymphatic Diseases
Diagnostic Study
Summary
Study start date: June 17, 2024
Actual date on which the first participant was enrolled.This study focuses on understanding how changes in body position affect hemoglobin levels in patients admitted to the intensive care unit (ICU). Hemoglobin is a crucial component of blood that carries oxygen throughout the body, and its levels are monitored to detect anemia. In ICU patients, who are often bedridden, changes in posture might cause the hemoglobin levels to fluctuate, leading to a condition called 'postural pseudoanemia.' This can result in unnecessary treatments like blood transfusions, which carry risks of adverse reactions. By studying this phenomenon in ICU patients, the research aims to prevent unnecessary interventions and improve patient care. In the study, ICU patients over the age of 18 will change their posture from lying down to sitting upright and then move to a chair. The researchers will measure the changes in hemoglobin levels during these movements. They will also look at other blood components like serum albumin, uric acid, CRP, and ESR to see if there's a correlation with hemoglobin changes. This process helps identify if the shifts in hemoglobin levels are significant and need medical attention. The main focus is to track the percentage change in hemoglobin to understand if posture changes lead to misleading low hemoglobin readings that could affect patient treatment decisions.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.24 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location